BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patientsStefanie Gilli, Thomas Pabst, Urban Novak et al.|Annals of Hematology|2016Cited by 42
High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patientsIrene Prediletto, Thomas Pabst, Daniel Betticher et al.|Bone Marrow Transplantation|2019Cited by 20
Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograftU Gössi, Thomas Pabst, Barbara Jeker et al.|Hematological Oncology|2018Cited by 16
Prolonged survival with increasing duration of lenalidomide maintenance after autologous transplant for multiple myelomaIsabel G. Amsler, Thomas Pabst, Barbara Jeker et al.|Leukemia & lymphoma/Leukemia and lymphoma|2019Cited by 15
Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicityBeatrice U. Mueller, Thomas Pabst, Sandra Keller et al.|Leukemia & lymphoma/Leukemia and lymphoma|2015Cited by 10